Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFudan University
About this trial
We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease
Eligibility criteria
Qualifiers
18 to 80 years old;
PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization;
Patients completed both pre- and post-operative MRI workups;
Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.
Disqualifiers
Patients has participated in other clinical studies;
Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/ severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate<60 ml/min)
Any allergic constitution;
Pregnancy and childbirth;
Trial design
Treatments tested in this trial
- DCE MRI
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov